Cancer #drugshortages have affected generic, essential medicines that should be widely available to all. Our patients deserve more. That’s why I urge you to join me and ASCO in asking our lawmakers to find solutions to this crisis: asco.org/ImpossibleChoi… #ASCOAdvocacy

And the story is not over yet! 43 cohorts reported in abstracts or manuscripts. All results to date posted on ASCO.org.

During this #GlobalVolunteerMonth & #NationalVolunteerWeek, our CEO Clifford Hudis expresses a heartfelt ‘thank you’ to our many volunteers for their time, energy, thought leadership & expertise. Thank YOU for your service to ASCO!

Join the virtual Grand Rounds on May 6 to learn the latest from the #TAPUR Study, an ongoing clinical trial investigating targeted therapies for advanced cancer. Speakers: Richard Schilsky Pam Mangat-Dhaliwal Janet Freeman-Daily, Jens Reuter Register: brnw.ch/21wICef #PrecisionMedicine

During this #GlobalVolunteerMonth & #NationalVolunteerWeek, I’d like to honor and celebrate the impact of our many volunteers, who serve as the backbone to the work we do. I'm also excited to announce on behalf of ASCO our newest committee chairs: brnw.ch/21wJ5qe

Excited to participate in the upcoming Hope For Stomach Cancer's Patient Empowerment Summit May 5-6 bringing together various stakeholders and members of the community to advance science and improve outcomes. Will be highlighting ASCO #TAPUR Study led by Study PI Richard Schilsky

Thank you STAT for an engaging evening bringing together policymakers, patient advocates, and industry leaders to discuss how policy decisions impact quality and access to healthcare. Pictured: Helmy Eltoukhy, Co-CEO Guardant Health discussing utility of liquid biopsies

Thank you Carmen Calfa, MD and colleagues Sylvester Comprehensive Cancer Center for organizing a terrific meeting!

ASCO's TAPUR Study Principal Investigator Richard Schilsky discussing ASCO #TAPUR at 2nd Biennial Miami Precision Medicine 2024! The study is actively enrolling with 43 cohorts reported to date, 20 positive, 23 negative, and many more to come Carmen Calfa, MD Sylvester Comprehensive Cancer Center

Thank you, Hope For Stomach Cancer for an engaging Patient Empowerment Summit for the opportunity to speak to ASCO's clinical research and the #TAPUR Study. Inspiring to hear patients and advocates and to collaborate w Dr. John Marshall Colorectal Cancer Alliance

Thank you OncoDaily for hosting a special night highlighting key leaders in the field. Congratulations, Vivek Subbiah, MD!

CDK study by ASCO discussed in advocate lounge this am. Janice Cowden patient advocate, Pam Mangat-Dhaliwal representing ASCO, & co-investigator Erica Mayer, Dana-Farber’s Breast Oncology Center. Dr. Mayer, describing MTD & how dosing is determined today in most cases: “Frankly, it’s barbaric”. #ASCO24

Day 4 Il Presidente Eletto AIOM, Massimo Di Maio, Pam Mangat-Dhaliwal, MS, PhD candidate, Division Director, Clinical Research and Analytics, Center for Research and Analytics (CENTRA), ASCO, e il Direttore della Comunicazione AIOM, riuniti a Chicago all’ASCO24. #ASCO24

Great to spend time with ASCO #TAPUR leadership team to plan for the future of the study!

Presenting ASCO CDK Study to the patient advocacy community at #ASCO24. Dose optimization trial for patients with metastatic breast cancer recruiting this Fall Study PI: Julie Gralow CoPIs: Erica Mayer Dawn Hershman Patient Partner Janice Cowden Statistician: Liz Garrett-Mayer, PhD

When ASCO brings together some of your favorites Richard Schilsky Liz Garrett-Mayer, PhD . Looking forward to the future of #TAPUR and ASCO clinical research!

The first pic..watch out! Powerful women at work! Julie Gralow Eric J. Small, MD, FASCO Lynn Schuchter. Cheers to another successful ASCO bringing together global leaders in oncology. @NCIGopal Enrique Soto Manmeet Ahluwalia, MD, MBA, FASCO Vivek Subbiah, MD #ASCO24 #globaloncology #precisiononcology #clinicaltrials

Powerful women at work! - Pam Mangat-Dhaliwal Julie Gralow Eric J. Small, MD, FASCO Lynn Schuchter ASCO @NCIGopal Enrique Soto Manmeet Ahluwalia, MD, MBA, FASCO Vivek Subbiah, MD oncodaily.com/81095.html #ASCO #Oncology #Leadership #OncoDaily #WomenInMedicine #Cancer #ASCO24

Thank you, Dr. Robin Zon, ASCO President 2024-2025, for participating in ASCO’s staff town hall and sharing valuable insights from the community oncologist perspective and highlighting the intersection between research, business, technology, clinical care, community, and advocacy

Don’t miss your chance to attend this growing ASCO meeting in Yokohama. Check out the abstract titles NOW to get a preview of the great science being presented and Register TODAY at conferences.asco.org/breakthrough/